Enhancer ID: | E_01_0569 |
Species: | human |
Position : | chrX:15492185-15494185 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | The novel coronavirus |
Pubmed ID: | 32511315 |
Enhancer experiment: | ChIP-seq?RNA-seq |
Enhancer experiment description: | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
Target gene : | ACE2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
TF name : | -- |
TF experiment: | ChIP-seq?RNA-seq |
TF experiment description: | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
Enhancer function : | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|